Lambda Nu Technology LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Aug 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 28, 2027The maintenance fee for Detection of lead electrode dislodgement using cavitary electrogram (US 10,543,364) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
- 1 fee due Sep 1, 2027The maintenance fee for Method for detecting and localizing insulation failures of implantable device leads (US 9,272,150) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,827,416 | Method and apparatus for detection of lead conductor anomalies using dynamic electrical parameters In force · From the USPTO record | In force | From the USPTO record | |
| US 9,272,150 | Method for detecting and localizing insulation failures of implantable device leads In force · From the USPTO record | In force | From the USPTO record | |
| US 9,427,577 | Method for detecting and treating insulation lead-to-housing failures In force · From the USPTO record | In force | From the USPTO record | |
| US 9,987,485 | Method and apparatus for implantable cardiac lead integrity analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 10,792,493 | Method and apparatus for implantable cardiac lead integrity analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 9,675,799 | Method and apparatus for implantable cardiac lead integrity analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 10,195,420 | Detection of implantable lead failures by differential EGM analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 9,636,500 | Active surveillance of implanted medical leads for lead integrity In force · From the USPTO record | In force | From the USPTO record | |
| US 9,486,624 | Detection of implantable lead failures by differential EGM analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 10,039,919 | Methods and apparatus for detecting and localizing partial conductor failures of implantable device leads In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 14: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.